Research Article

Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)

Table 4

Results of univariate and multivariable analysis for disease-specific survival in the entire study cohort.

UnivariateMultivariable
HR
(95% CI)
valueAdjusted HR
(95% CI)
value

Age0.0460.012
 <40ReferenceReference
 40-591.31 (0.85-2.03)0.2261.27 (0.81-1.99)0.303
 60-791.54 (0.99-2.38)0.0561.76 (1.12-2.75)0.013
 ≥802.38 (1.16-4.85)0.0182.16 (1.04-4.48)0.038
Sex0.0140.009
 MaleReferenceReference
 Female0.74 (0.58-0.94)0.0140.69 (0.54-0.89)0.004
Race0.584
 WhiteReference
 Black0.99 (0.68-1.44)0.962
 Hispanic0.81 (0.54-1.21)0.306
 Asian0.70 (0.43-1.15)0.162
 Other0.84 (0.27-2.61)0.757
Marital status0.0160.040
 UnmarriedReferenceReference
 Married0.81 (0.63-1.04)0.0100.72 (0.55-0.94)0.016
 Unknown0.63 (0.33-1.20)0.0160.62 (0.32-1.21)0.163
Insurance status<0.0010.007
 UninsuredReferenceReference
 Insured0.54 (0.28-1.06)0.0750.52 (0.26-1.04)0.065
 Unknown1.08 (0.54-2.16)0.8360.80 (0.39-1.63)0.533
Tumor location0.0110.064
 HeadReferenceReference
 Body and tail0.69 (0.50-0.84)0.0010.71 (0.54-0.93)0.012
 Overlapping0.98 (0.59-1.61)0.9250.81 (0.49-1.36)0.429
 Other0.79 (0.53-1.18)0.2541.01 (0.67-1.53)0.951
Tumor size<0.0010.014
 <2 cmReferenceReference
 2 cm-4 cm3.05 (1.90-4.90)<0.0011.90 (1.17-3.11)0.010
 >4 cm5.02 (3.18-7.91)<0.0012.23 (1.37-3.62)0.001
 Unknown0.9480.940
M stage<0.001<0.001
 M0ReferenceReference
 M14.89 (3.85-6.21)<0.0013.21 (2.47-4.16)<0.001
 Mx1.44 (0.36-5.81)0.6111.21 (0.30-4.95)0.792
Histology grade<0.001<0.001
 Well differentiatedReferenceReference
 Moderately differentiated1.73 (1.20-2.50)0.0641.32 (0.91-1.92)0.144
 Poorly differentiated8.45 (6.11-11.68)<0.0014.64 (3.31-6.49)<0.001
 Undifferentiated10.61 (5.81-19.39)<0.0017.65 (4.10-14.27)<0.001
 Unknown2.15 (1.56-2.95)<0.0011.69 (1.21-2.36)0.002
Lymph node metastasis<0.001<0.001
 No metastasisReferenceReference
 Metastasis3.63 (2.80-4.72)<0.0011.87 (1.41-2.48)<0.001